These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 30165526)
1. Marburg Virus Viral Protein 35 Inhibits Protein Kinase R Activation in a Cell Type-Specific Manner. Hume A; Mühlberger E J Infect Dis; 2018 Nov; 218(suppl_5):S403-S408. PubMed ID: 30165526 [TBL] [Abstract][Full Text] [Related]
2. Impact of Měnglà Virus Proteins on Human and Bat Innate Immune Pathways. Williams CG; Gibbons JS; Keiffer TR; Luthra P; Edwards MR; Basler CF J Virol; 2020 Jun; 94(13):. PubMed ID: 32295912 [TBL] [Abstract][Full Text] [Related]
3. Innate Immune Responses of Bat and Human Cells to Filoviruses: Commonalities and Distinctions. Kuzmin IV; Schwarz TM; Ilinykh PA; Jordan I; Ksiazek TG; Sachidanandam R; Basler CF; Bukreyev A J Virol; 2017 Apr; 91(8):. PubMed ID: 28122983 [TBL] [Abstract][Full Text] [Related]
4. Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells. Feagins AR; Basler CF Virology; 2015 Nov; 485():145-52. PubMed ID: 26255028 [TBL] [Abstract][Full Text] [Related]
6. Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of Host immune responses. Albariño CG; Wiggleton Guerrero L; Spengler JR; Uebelhoer LS; Chakrabarti AK; Nichol ST; Towner JS Virology; 2015 Feb; 476():85-91. PubMed ID: 25531184 [TBL] [Abstract][Full Text] [Related]
7. Evasion of interferon responses by Ebola and Marburg viruses. Basler CF; Amarasinghe GK J Interferon Cytokine Res; 2009 Sep; 29(9):511-20. PubMed ID: 19694547 [TBL] [Abstract][Full Text] [Related]
8. Effects of Filovirus Interferon Antagonists on Responses of Human Monocyte-Derived Dendritic Cells to RNA Virus Infection. Yen BC; Basler CF J Virol; 2016 May; 90(10):5108-5118. PubMed ID: 26962215 [TBL] [Abstract][Full Text] [Related]
9. Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism. Bale S; Julien JP; Bornholdt ZA; Kimberlin CR; Halfmann P; Zandonatti MA; Kunert J; Kroon GJ; Kawaoka Y; MacRae IJ; Wilson IA; Saphire EO PLoS Pathog; 2012 Sep; 8(9):e1002916. PubMed ID: 23028316 [TBL] [Abstract][Full Text] [Related]
10. Crystal Structure of the Marburg Virus Nucleoprotein Core Domain Chaperoned by a VP35 Peptide Reveals a Conserved Drug Target for Filovirus. Zhu T; Song H; Peng R; Shi Y; Qi J; Gao GF J Virol; 2017 Sep; 91(18):. PubMed ID: 28659479 [TBL] [Abstract][Full Text] [Related]
11. Crystal Structure of the Marburg Virus VP35 Oligomerization Domain. Bruhn JF; Kirchdoerfer RN; Urata SM; Li S; Tickle IJ; Bricogne G; Saphire EO J Virol; 2017 Jan; 91(2):. PubMed ID: 27847355 [TBL] [Abstract][Full Text] [Related]
12. Rousette Bat Dendritic Cells Overcome Marburg Virus-Mediated Antiviral Responses by Upregulation of Interferon-Related Genes While Downregulating Proinflammatory Disease Mediators. Prescott J; Guito JC; Spengler JR; Arnold CE; Schuh AJ; Amman BR; Sealy TK; Guerrero LW; Palacios GF; Sanchez-Lockhart M; Albariño CG; Towner JS mSphere; 2019 Dec; 4(6):. PubMed ID: 31801842 [TBL] [Abstract][Full Text] [Related]
13. Structural Insight into Nucleoprotein Conformation Change Chaperoned by VP35 Peptide in Marburg Virus. Liu B; Dong S; Li G; Wang W; Liu X; Wang Y; Yang C; Rao Z; Guo Y J Virol; 2017 Aug; 91(16):. PubMed ID: 28566377 [TBL] [Abstract][Full Text] [Related]
14. Differential Regulation of Interferon Responses by Ebola and Marburg Virus VP35 Proteins. Edwards MR; Liu G; Mire CE; Sureshchandra S; Luthra P; Yen B; Shabman RS; Leung DW; Messaoudi I; Geisbert TW; Amarasinghe GK; Basler CF Cell Rep; 2016 Feb; 14(7):1632-1640. PubMed ID: 26876165 [TBL] [Abstract][Full Text] [Related]
15. Phosphorylated VP30 of Marburg Virus Is a Repressor of Transcription. Tigabu B; Ramanathan P; Ivanov A; Lin X; Ilinykh PA; Parry CS; Freiberg AN; Nekhai S; Bukreyev A J Virol; 2018 Nov; 92(21):. PubMed ID: 30135121 [TBL] [Abstract][Full Text] [Related]
16. Marburg virus evades interferon responses by a mechanism distinct from ebola virus. Valmas C; Grosch MN; Schümann M; Olejnik J; Martinez O; Best SM; Krähling V; Basler CF; Mühlberger E PLoS Pathog; 2010 Jan; 6(1):e1000721. PubMed ID: 20084112 [TBL] [Abstract][Full Text] [Related]
17. Novel activities by ebolavirus and marburgvirus interferon antagonists revealed using a standardized in vitro reporter system. Guito JC; Albariño CG; Chakrabarti AK; Towner JS Virology; 2017 Jan; 501():147-165. PubMed ID: 27930961 [TBL] [Abstract][Full Text] [Related]
19. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. Feng Z; Cerveny M; Yan Z; He B J Virol; 2007 Jan; 81(1):182-92. PubMed ID: 17065211 [TBL] [Abstract][Full Text] [Related]
20. The cellular protein phosphatase 2A is a crucial host factor for Marburg virus transcription. von Creytz I; Rohde C; Biedenkopf N J Virol; 2024 Sep; 98(9):e0104724. PubMed ID: 39194238 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]